U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT06833775) titled 'Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRI' on Feb. 13.
Brief Summary: This study aims to predict the efficacy of different types of neoadjuvant therapy and related postoperative pathological indicators in patients with esophageal cancer based on imaging parameters from CT and multimodal MRI, as well as clinical indicators collected before and after neoadjuvant treatment.
Study Start Date: March, 2025
Study Type: OBSERVATIONAL
Condition:
Esophageal Cancer
Neoadjuvant Therapy
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Henan Cancer Ho...